Vanda Pharmaceuticals (VNDA) Tax Provisions: 2010-2025
Historic Tax Provisions for Vanda Pharmaceuticals (VNDA) over the last 11 years, with Sep 2025 value amounting to -$5.8 million.
- Vanda Pharmaceuticals' Tax Provisions fell 530.87% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year decrease of 1245.96%. This contributed to the annual value of -$4.0 million for FY2024, which is 204.99% down from last year.
- Per Vanda Pharmaceuticals' latest filing, its Tax Provisions stood at -$5.8 million for Q3 2025, which was up 24.62% from -$7.7 million recorded in Q2 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Tax Provisions peaked at $3.0 million during Q2 2021, and registered a low of -$7.9 million during Q1 2025.
- For the 3-year period, Vanda Pharmaceuticals' Tax Provisions averaged around -$2.0 million, with its median value being -$920,000 (2024).
- In the last 5 years, Vanda Pharmaceuticals' Tax Provisions soared by 302.82% in 2023 and then slumped by 1,425.10% in 2025.
- Vanda Pharmaceuticals' Tax Provisions (Quarterly) stood at $1.5 million in 2021, then surged by 80.22% to $2.7 million in 2022, then slumped by 73.21% to $730,000 in 2023, then plummeted by 317.12% to -$1.6 million in 2024, then tumbled by 530.87% to -$5.8 million in 2025.
- Its last three reported values are -$5.8 million in Q3 2025, -$7.7 million for Q2 2025, and -$7.9 million during Q1 2025.